ResultsIQ › Latest results › GPT Healthcare Limited
GPT Healthcare Limited Q2 FY27 results deck summary
NSE: GPTHEALTH · BSE: 544131
Results deck of 5 Nov 2026, summarised by AI from the filing.
GPT Healthcare Q2 FY27 revenue ₹135.6 cr, EBITDA ₹29.8 cr at 21.5% margin and PAT ₹15.4 cr, with network occupancy at 50.3%.
Key takeaways
- Occupancy Network occupancy improved to 50.3% in Q2 FY27 from 47.4%, and was 59.8% excluding Raipur.
- Growth driver ARPOB grew 7.1% YoY to ₹40,721 on a stronger clinical offering, favourable speciality mix and operational efficiencies.
- Main risk Raipur occupancy was only 16.5% in Q2 FY27, weighing on network utilisation.
GPT Healthcare Limited Q2 FY27 results
As filed: Revenue ₹136 cr (+14% year on year), EBITDA ₹26.9 cr (+17% year on year), PAT ₹15.4 cr (+40% year on year), EBITDA margin 19.8% (+50 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹126 cr (+18% year on year), EBITDA ₹24.2 cr (+42% year on year), PAT ₹12.7 cr (+59% year on year), EBITDA margin 19.2% (+326 bps). Score 85 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 326 bps year on year. Profit fell 13% from last quarter. Share price after the results: −8.0% in 30 days (Nifty 500: −2.4%).
- Q4 FY26: Revenue ₹126 cr (+25% year on year), EBITDA ₹23.4 cr (+17% year on year), PAT ₹14.6 cr (+12% year on year), EBITDA margin 18.5% (−132 bps). Score 82 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was above it. EBITDA margin fell 132 bps year on year. Tax rate 8%. Share price after the results: +4.4% in 30 days (Nifty 500: +2.9%).
- Q3 FY26: Revenue ₹120 cr (+18% year on year), EBITDA ₹20.7 cr (−6% year on year), PAT ₹9.4 cr (−22% year on year), EBITDA margin 17.2% (−433 bps). Score 47 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 433 bps year on year. Profit fell 15% from last quarter. Share price after the results: −5.7% in 30 days (Nifty 500: −1.9%).
- Q2 FY26: Revenue ₹119 cr (+12% year on year), EBITDA ₹23.0 cr (−4% year on year), PAT ₹11.0 cr (−27% year on year), EBITDA margin 19.3% (−331 bps). Score 30 of 100, Below trend. EBITDA margin fell 331 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −5.4% in 30 days (Nifty 500: 0.0%).
- Q1 FY26: Revenue ₹107 cr (+9% year on year), EBITDA ₹17.0 cr (−11% year on year), PAT ₹8.0 cr (−20% year on year), EBITDA margin 15.9% (−350 bps). Score 27 of 100, Below trend. EBITDA margin fell 350 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 38% from last quarter. Share price after the results: −13.8% in 30 days (Nifty 500: +0.7%).
- Q4 FY25: Revenue ₹101 cr (+2% year on year), EBITDA ₹20.0 cr (−13% year on year), PAT ₹13.0 cr (0% year on year), EBITDA margin 19.8% (−343 bps). Score 24 of 100, Below trend. EBITDA margin fell 343 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −7.6% in 28 days (Nifty 500: +1.1%).
- Q3 FY25: Revenue ₹102 cr (+5% year on year), EBITDA ₹22.0 cr (0% year on year), PAT ₹12.0 cr (+9% year on year), EBITDA margin 21.6% (−111 bps). Score 36 of 100, Below trend. EBITDA margin fell 111 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 4% from last quarter.
Past price moves after results do not indicate future moves. Not a recommendation.
GPT Healthcare Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (6 Nov 2026), Results deck (5 Nov 2026), Results press release (5 Nov 2026)
- Q1 FY27: Earnings call (4 Aug 2026), Results deck (3 Aug 2026)
- Q4 FY26: Earnings call (19 May 2026), Results deck (18 May 2026), Results press release (18 May 2026)
- Q3 FY26: Earnings call (3 Feb 2026), Results deck (2 Feb 2026), Results press release (2 Feb 2026)
- Q2 FY26: Earnings call (11 Nov 2025), Results deck (8 Nov 2025), Results press release (8 Nov 2025)
- Q1 FY26: Earnings call (7 Aug 2025), Results deck (6 Aug 2025), Results press release (6 Aug 2025)
- Q4 FY25: Earnings call (24 May 2025), Results deck (23 May 2025), Results press release (23 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.